Skip to main content
. 2020 Oct 12;14(1):405–411. doi: 10.1111/cts.12893

Table 4.

Adverse events between DDGP and SMILE groups

Toxicity Grade of adverse reaction P value
DDGP (N = 31) SMILE (N = 23)
Grade 0 1/2 3/4 0 1/2 3/4
Hematologic
Leukopenia 1 12 18 0 3 20 0.021*
Neutropenia 0 10 21 0 2 21 0.041*
Anemia 3 12 16 1 10 12 0.829
Thrombocytopenia 2 11 18 2 6 15 0.677
Nonhematologic
Hypofibrinogenemia 13 17 1 12 9 2 0.637
Prolonged APTT 18 13 0 16 7 0 0.391
Hyperbilirubinemia 23 7 1 18 3 2 0.833
ALT elevation 12 19 0 11 7 5 0.771
AST elevation 14 17 0 12 6 5 0.734
Creatinine 29 2 0 20 3 0 0.413
BUN 29 2 0 20 3 0 0.413
Nausea/vomiting 0 23 8 0 18 5 0.732
Mucositis 31 0 0 21 2 0 0.097
Allergy 31 0 0 20 2 1 0.040*

ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; BUN, blood urea nitrogen; DDGP, cisplatin, dexamethasone, gemcitabine, and pegaspargase; SMILE, methotrexate, dexamethasone, ifosfamide, L‐asparaginase, and etoposide.

*

P < 0.05.